Emtricitabine, Rilpivirine, and Tenofovir Alafenamide and Renal impairment
Result of checking the interaction of drug Emtricitabine, Rilpivirine, and Tenofovir Alafenamide and disease Renal impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Rilpivirine should be used with caution in patients with severe renal impairment or end-stage renal disease, as drug concentrations can be increased due to alteration of drug absorption, distribution, and metabolism secondary to renal dysfunction. No dose adjustment is required in patients with mild or moderate renal impairment.
Generic Name: emtricitabine / rilpivirine / tenofovir alafenamide
Brand Name: Odefsey, Complera
Synonyms: n.a.